ReP USP - Resultado da busca

Artigo de periodico
Up-regulation of chemokine C–C ligand 2 (CCL2) and C-X-C chemokine 8 (CXCL8) expression by monocytes in chronic idiopathic urticaria (2012)
Santos, J. C.; Brito, C. A. de; Futata, E. A.; Azor, M. H.; Orii, N. M.; Maruta, C. W.; Rivitti, E. A.; Duarte, A. J. S.; Sato, M. N.
Source: Clinical and experimental immunology. Unidade: FM
Subjects: URTICÁRIA (EPIDEMIOLOGIA), AUTOIMUNIDADE, DOENÇAS AUTOIMUNES, MONÓCITOS (IMUNOLOGIA), AUTOANTICORPOS (IMUNOLOGIA), DOENÇA CRÔNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, J. C. et al. Up-regulation of chemokine C–C ligand 2 (CCL2) and C-X-C chemokine 8 (CXCL8) expression by monocytes in chronic idiopathic urticaria. Clinical and experimental immunology, n. 1, p. 129-136, 2012Tradução . . Disponível em: http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2249.2011.04485.x/pdf. Acesso em: 18 nov. 2024.
APA
Santos, J. C., Brito, C. A. de, Futata, E. A., Azor, M. H., Orii, N. M., Maruta, C. W., et al. (2012). Up-regulation of chemokine C–C ligand 2 (CCL2) and C-X-C chemokine 8 (CXCL8) expression by monocytes in chronic idiopathic urticaria. Clinical and experimental immunology, ( 1), 129-136. doi:10.1111/j.1365-2249.2011.04485.x
NLM
Santos JC, Brito CA de, Futata EA, Azor MH, Orii NM, Maruta CW, Rivitti EA, Duarte AJS, Sato MN. Up-regulation of chemokine C–C ligand 2 (CCL2) and C-X-C chemokine 8 (CXCL8) expression by monocytes in chronic idiopathic urticaria [Internet]. Clinical and experimental immunology. 2012 ;( 1): 129-136.[citado 2024 nov. 18 ] Available from: http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2249.2011.04485.x/pdf
Vancouver
Santos JC, Brito CA de, Futata EA, Azor MH, Orii NM, Maruta CW, Rivitti EA, Duarte AJS, Sato MN. Up-regulation of chemokine C–C ligand 2 (CCL2) and C-X-C chemokine 8 (CXCL8) expression by monocytes in chronic idiopathic urticaria [Internet]. Clinical and experimental immunology. 2012 ;( 1): 129-136.[citado 2024 nov. 18 ] Available from: http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2249.2011.04485.x/pdf
Artigo de periodico
Serum titres of anti-glutamic acid decarboxylase-65 and anti-IA-2 autoantibodies are associated with different immunoregulatory milieu in newly diagnosed type 1 diabetes patients (2012)
Gabbay, M. Andrade Lima; Sato, M. N.; Duarte, A. J. S.; Dib, S. A.
Source: Clinical and experimental immunology. Unidade: FM
Subjects: CITOCINA (ANÁLISE), PÂNCREAS (IMUNOLOGIA), DIABETES MELLITUS INSULINO-DEPENDENTE (DIAGNÓSTICO;IMUNOLOGIA), LINFÓCITOS T (ANÁLISE), AUTOANTICORPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GABBAY, M. Andrade Lima et al. Serum titres of anti-glutamic acid decarboxylase-65 and anti-IA-2 autoantibodies are associated with different immunoregulatory milieu in newly diagnosed type 1 diabetes patients. Clinical and experimental immunology, n. 1, p. 60-67, 2012Tradução . . Disponível em: http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2249.2011.04538.x/pdf. Acesso em: 18 nov. 2024.
APA
Gabbay, M. A. L., Sato, M. N., Duarte, A. J. S., & Dib, S. A. (2012). Serum titres of anti-glutamic acid decarboxylase-65 and anti-IA-2 autoantibodies are associated with different immunoregulatory milieu in newly diagnosed type 1 diabetes patients. Clinical and experimental immunology, ( 1), 60-67. doi:10.1111/j.1365-2249.2011.04538.x
NLM
Gabbay MAL, Sato MN, Duarte AJS, Dib SA. Serum titres of anti-glutamic acid decarboxylase-65 and anti-IA-2 autoantibodies are associated with different immunoregulatory milieu in newly diagnosed type 1 diabetes patients [Internet]. Clinical and experimental immunology. 2012 ;( 1): 60-67.[citado 2024 nov. 18 ] Available from: http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2249.2011.04538.x/pdf
Vancouver
Gabbay MAL, Sato MN, Duarte AJS, Dib SA. Serum titres of anti-glutamic acid decarboxylase-65 and anti-IA-2 autoantibodies are associated with different immunoregulatory milieu in newly diagnosed type 1 diabetes patients [Internet]. Clinical and experimental immunology. 2012 ;( 1): 60-67.[citado 2024 nov. 18 ] Available from: http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2249.2011.04538.x/pdf
Artigo de periodico
Serum titres of anti-glutamic acid decarboxylase-65 and anti-IA-2 autoantibodies are associated with different immunoregulatory milieu in newly diagnosed type 1 diabetes patients (2011)
Gabbay, M. Andrade Lima; Duarte, A. J. S; Sato, M. N.
Source: Clinical and experimental immunology. Unidade: FM
Subjects: AUTOANTICORPOS, DIABETES MELLITUS INSULINO-DEPENDENTE (EPIDEMIOLOGIA;DIAGNÓSTICO), GLUTAMINA, CITOCINAS, PÂNCREAS (IMUNOLOGIA), DIABETES MELLITUS INSULINO-DEPENDENTE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GABBAY, M. Andrade Lima e DUARTE, A. J. S e SATO, M. N. Serum titres of anti-glutamic acid decarboxylase-65 and anti-IA-2 autoantibodies are associated with different immunoregulatory milieu in newly diagnosed type 1 diabetes patients. Clinical and experimental immunology, v. 168, n. 1, p. 60-67, 2011Tradução . . Disponível em: https://doi.org/10.1111/j.1365-2249.2011.04538.x. Acesso em: 18 nov. 2024.
APA
Gabbay, M. A. L., Duarte, A. J. S., & Sato, M. N. (2011). Serum titres of anti-glutamic acid decarboxylase-65 and anti-IA-2 autoantibodies are associated with different immunoregulatory milieu in newly diagnosed type 1 diabetes patients. Clinical and experimental immunology, 168( 1), 60-67. doi:10.1111/j.1365-2249.2011.04538.x
NLM
Gabbay MAL, Duarte AJS, Sato MN. Serum titres of anti-glutamic acid decarboxylase-65 and anti-IA-2 autoantibodies are associated with different immunoregulatory milieu in newly diagnosed type 1 diabetes patients [Internet]. Clinical and experimental immunology. 2011 ; 168( 1): 60-67.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1111/j.1365-2249.2011.04538.x
Vancouver
Gabbay MAL, Duarte AJS, Sato MN. Serum titres of anti-glutamic acid decarboxylase-65 and anti-IA-2 autoantibodies are associated with different immunoregulatory milieu in newly diagnosed type 1 diabetes patients [Internet]. Clinical and experimental immunology. 2011 ; 168( 1): 60-67.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1111/j.1365-2249.2011.04538.x
Artigo de periodico
Statin effects on regulatory and proinflammatory factors in chronic idiopathic urticaria (2011)
Azor, M. H; Santos, J. C. dos; Futata, E. A; Brito, C. A. de; Maruta, Celina Wakisaka; Rivitti, Evandro Ararigbóia; Duarte, Alberto José da Silva; Sato, Maria natomi
Source: Clinical and experimental immunology. Unidade: FM
Subjects: URTICÁRIA (TERAPIA;REGULAÇÃO), DOENÇA CRÔNICA, CITOCINAS, INFLAMAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AZOR, M. H et al. Statin effects on regulatory and proinflammatory factors in chronic idiopathic urticaria. Clinical and experimental immunology, n. 2, p. 291-298, 2011Tradução . . Disponível em: https://doi.org/10.1111/j.1365-2249.2011.04473.x. Acesso em: 18 nov. 2024.
APA
Azor, M. H., Santos, J. C. dos, Futata, E. A., Brito, C. A. de, Maruta, C. W., Rivitti, E. A., et al. (2011). Statin effects on regulatory and proinflammatory factors in chronic idiopathic urticaria. Clinical and experimental immunology, ( 2), 291-298. doi:10.1111/j.1365-2249.2011.04473.x
NLM
Azor MH, Santos JC dos, Futata EA, Brito CA de, Maruta CW, Rivitti EA, Duarte AJ da S, Sato M natomi. Statin effects on regulatory and proinflammatory factors in chronic idiopathic urticaria [Internet]. Clinical and experimental immunology. 2011 ;( 2): 291-298.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1111/j.1365-2249.2011.04473.x
Vancouver
Azor MH, Santos JC dos, Futata EA, Brito CA de, Maruta CW, Rivitti EA, Duarte AJ da S, Sato M natomi. Statin effects on regulatory and proinflammatory factors in chronic idiopathic urticaria [Internet]. Clinical and experimental immunology. 2011 ;( 2): 291-298.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1111/j.1365-2249.2011.04473.x
Artigo de periodico
Up-regulation of chemokine C–C ligand 2 (CCL2) and C-X-C chemokine 8 (CXCL8) expression by monocytes in chronic idiopathic urticaria (2011)
Santos, J. C.; Brito, C. A. de; Futata, E. A.; Azor,M. H.; Orii, N. M.; Maruta, C. W.; Rivitti, E. A.; Duarte, A. J. S; Sato, M. N.
Source: Clinical and experimental immunology. Unidade: FM
Subjects: DOENÇA CRÔNICA, URTICÁRIA, IMUNIDADE, MONÓCITOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, J. C. et al. Up-regulation of chemokine C–C ligand 2 (CCL2) and C-X-C chemokine 8 (CXCL8) expression by monocytes in chronic idiopathic urticaria. Clinical and experimental immunology, v. 167, n. 1, p. 129-136, 2011Tradução . . Disponível em: https://doi.org/10.1111/j.1365-2249.2011.04485.x. Acesso em: 18 nov. 2024.
APA
Santos, J. C., Brito, C. A. de, Futata, E. A., Azor, M. H., Orii, N. M., Maruta, C. W., et al. (2011). Up-regulation of chemokine C–C ligand 2 (CCL2) and C-X-C chemokine 8 (CXCL8) expression by monocytes in chronic idiopathic urticaria. Clinical and experimental immunology, 167( 1), 129-136. doi:10.1111/j.1365-2249.2011.04485.x
NLM
Santos JC, Brito CA de, Futata EA, Azor MH, Orii NM, Maruta CW, Rivitti EA, Duarte AJS, Sato MN. Up-regulation of chemokine C–C ligand 2 (CCL2) and C-X-C chemokine 8 (CXCL8) expression by monocytes in chronic idiopathic urticaria [Internet]. Clinical and experimental immunology. 2011 ; 167( 1): 129-136.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1111/j.1365-2249.2011.04485.x
Vancouver
Santos JC, Brito CA de, Futata EA, Azor MH, Orii NM, Maruta CW, Rivitti EA, Duarte AJS, Sato MN. Up-regulation of chemokine C–C ligand 2 (CCL2) and C-X-C chemokine 8 (CXCL8) expression by monocytes in chronic idiopathic urticaria [Internet]. Clinical and experimental immunology. 2011 ; 167( 1): 129-136.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1111/j.1365-2249.2011.04485.x

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects